During Monday's anniversary program of Mad Money, one caller during the "Lightning Round" segment asked about Exact Sciences (EXAS) : "I think they are problem solvers and I have liked Exact Sciences for a long time," responded Jim Cramer.
More from Investing
Last week was rather tough across the board for equities. The Autos were different.
This quartet of stocks has had a rough go of it in 2021 but could rebound in the coming year.
The shares have weakened significantly the past 12 months.
Small-cap biotech Marker Therapeutics and online appliance seller 1847 Goedeker have been beaten down lately but offer hope for bouncing back.
The technical signals are indicating that the stock of the Western apparel retailer may be running out of steam after a long run higher this year.